TickerFacts.

A business in context

VXRT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-16 · 0001437749-26-033037

  2. 8-K · Current report

    Report date 2026-10-16 · 0001437749-26-032932 · Items 5.02,7.01,9.01

  3. 8-K · Current report

    Report date 2026-09-03 · 0001437749-26-030318 · Items 8.01

  4. 8-K · Current report

    Report date 2026-08-21 · 0001437749-26-028916 · Items 8.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-026289

  6. 8-K · Current report

    Report date 2026-08-06 · 0001437749-26-026280 · Items 2.02,9.01

  7. 8-K · Current report

    Report date 2026-07-27 · 0001437749-26-024560 · Items 8.01

  8. 4 · Ownership change

    Report date 2026-07-16 · 0001437749-26-023863

  9. 4 · Ownership change

    Report date 2026-07-16 · 0001437749-26-023810

  10. 4 · Ownership change

    Report date 2026-07-16 · 0001437749-26-023809

  11. 4 · Ownership change

    Report date 2026-07-16 · 0001437749-26-023808

  12. 4 · Ownership change

    Report date 2026-07-16 · 0001437749-26-023807

  13. 8-K · Current report

    Report date 2026-07-16 · 0001437749-26-023762 · Items 5.07,7.01,9.01

  14. 8-K · Current report

    Report date 2026-07-06 · 0001437749-26-022876 · Items 8.01,9.01

  15. 8-K · Current report

    Report date 2026-07-01 · 0001213900-26-074576 · Items 1.01,7.01,9.01

  16. 8-K · Current report

    Report date 2026-06-22 · 0001437749-26-021833 · Items 1.01,8.01,9.01

  17. 4 · Ownership change

    Report date 2026-05-22 · 0001437749-26-018385

  18. 4 · Ownership change

    Report date 2026-05-19 · 0001437749-26-018117

  19. 8-K · Current report

    Report date 2026-05-19 · 0001213900-26-059127 · Items 8.01,9.01

  20. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015608

  21. 8-K · Current report

    Report date 2026-05-07 · 0001437749-26-015586 · Items 2.02,9.01

  22. 10-K/A · Annual report

    Report date 2025-12-31 · 0001437749-26-014245

  23. 8-K · Current report

    Report date 2026-04-23 · 0001437749-26-013195 · Items 5.02,7.01,9.01

  24. 8-K · Current report

    Report date 2026-04-20 · 0001437749-26-012882 · Items 8.01

  25. 8-K · Current report

    Report date 2026-04-16 · 0001437749-26-012623 · Items 1.01,3.02,7.01,9.01

  26. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-008023

  27. 8-K · Current report

    Report date 2026-03-12 · 0001437749-26-007968 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-12-18 · 0001437749-25-038774 · Items 1.02

  29. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-034840

  30. 8-K · Current report

    Report date 2025-11-13 · 0001437749-25-034829 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-11-04 · 0001437749-25-033362 · Items 1.01,7.01,9.01

  32. 8-K · Current report

    Report date 2025-10-08 · 0001437749-25-030868 · Items 7.01

  33. 8-K · Current report

    Report date 2025-09-19 · 0001437749-25-029485 · Items 3.01

  34. 8-K · Current report

    Report date 2025-09-18 · 0001437749-25-029434 · Items 8.01

  35. 8-K · Current report

    Report date 2025-09-05 · 0001437749-25-028570 · Items 5.07,7.01,9.01

  36. 8-K · Current report

    Report date 2025-09-02 · 0001437749-25-028167 · Items 5.02,7.01,9.01

  37. 8-K · Current report

    Report date 2025-08-27 · 0001437749-25-028047 · Items 7.01,8.01,9.01

  38. 8-K · Current report

    Report date 2025-08-20 · 0001437749-25-027524 · Items 7.01,9.01

  39. 8-K · Current report

    Report date 2025-08-14 · 0001437749-25-027110 · Items 7.01,9.01

  40. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-026514

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 10 transaction rows10AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-16
2026-07-20
Finney KevinA · Grant / award
Acquired
Common Stock39400.00.0
2026-07-16
2026-07-20
Finney KevinA · Grant / award
Acquired
Stock Options (right to buy)
Derivative security
78700.00.0
2026-07-16
2026-07-17
BREITMEYER JAMES BA · Grant / award
Acquired
Common Stock8315.00.0
2026-07-16
2026-07-17
BREITMEYER JAMES BA · Grant / award
Acquired
Stock Options (right to buy)
Derivative security
16610.00.0
2026-07-16
2026-07-17
HERON ELAINE JA · Grant / award
Acquired
Common Stock39400.00.0
2026-07-16
2026-07-17
HERON ELAINE JA · Grant / award
Acquired
Stock Options (right to buy)
Derivative security
78700.00.0
2026-07-16
2026-07-17
Watson W. MarkA · Grant / award
Acquired
Common Stock39400.00.0
2026-07-16
2026-07-17
Watson W. MarkA · Grant / award
Acquired
Stock Options (right to buy)
Derivative security
78700.00.0
2026-07-16
2026-07-17
Wheadon David E.A · Grant / award
Acquired
Common Stock39400.00.0
2026-07-16
2026-07-17
Wheadon David E.A · Grant / award
Acquired
Stock Options (right to buy)
Derivative security
78700.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000072444Vaxart, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Vaxart · alias · wikidata
  • Aviragen Therapeutics, Inc. · former SEC name · 2016-04-26 to 2018-02-15
  • Biota Pharmaceuticals, Inc. · former SEC name · 2012-11-14 to 2016-04-13
  • NABI BIOPHARMACEUTICALS · former SEC name · 2010-07-21 to 2012-11-08
  • NABI BIOPHARMACEUTICALS · former SEC name · 2002-04-15 to 2010-06-29
  • NABI /DE/ · former SEC name · 1996-11-27 to 2002-02-14
  • NORTH AMERICAN BIOLOGICALS INC · former SEC name · 1994-11-08 to 1996-02-14
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$28.70M$30.83M
2023-12-31$7.38M$8.16M
2022-12-31$107.0K$123.2K
2021-12-31$892.0K$1.11M
2020-12-31$4.05M$5.27M
2019-12-31$9.86M$13.00M
2018-12-31$4.16M$5.58M
2017-12-31$5.84M$8.03M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗